These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1423041

  • 1. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy.
    Zochodne DW, Ho LT.
    Can J Neurol Sci; 1992 Nov; 19(4):433-41. PubMed ID: 1423041
    [Abstract] [Full Text] [Related]

  • 2. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE, Cotter MA.
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats.
    Cotter MA, Gibson TM, Nangle MR, Cameron NE.
    Diabetes Obes Metab; 2010 Aug; 12(8):689-99. PubMed ID: 20590746
    [Abstract] [Full Text] [Related]

  • 6. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
    Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK.
    Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
    [Abstract] [Full Text] [Related]

  • 7. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.
    Tuck RR, Schmelzer JD, Low PA.
    Brain; 1984 Sep 30; 107 ( Pt 3)():935-50. PubMed ID: 6478183
    [Abstract] [Full Text] [Related]

  • 13. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME, Cotter MA, Cameron NE.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):63-71. PubMed ID: 17291486
    [Abstract] [Full Text] [Related]

  • 14. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC.
    Neuroscience; 2007 Feb 23; 144(4):1293-304. PubMed ID: 17187935
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
    Skalska S, Kyselova Z, Gajdosikova A, Karasu C, Stefek M, Stolc S.
    Gen Physiol Biophys; 2008 Jun 23; 27(2):106-14. PubMed ID: 18645225
    [Abstract] [Full Text] [Related]

  • 16. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG, Kumar A, Sharma SS.
    Life Sci; 2006 Jul 17; 79(8):777-83. PubMed ID: 16581090
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.
    Exp Neurol; 2001 Apr 17; 168(2):259-72. PubMed ID: 11259114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.